The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Could cannabis become legal in London?
https://www.itv.com/news/london/2022-05-12/london-mayor-sadiq-khan-explores-legalising-cannabis-and-visits-la-drug-farm
Totally agree with you Curry.
There will be a huge demand for disposable Airplane seat covers (also used in Trains and Tourist Cars).
These will have massive potential and enhanced value, if it is coated with virucidal nanoparticles..
If you are still sceptical of usage of masks by general public post vaccination, here is a list where it will be needed forever.
Market is massive than you imagine! Stay calm and have trust in your decision!
1) World Health Organization ("To meet rising global demand, WHO estimates that industry must increase manufacturing of PPE by 40 per cent.") - Purchase & Distribute to at-risk countries
2) Hospitals throughout the globe
3) Dental Clinics
4) Veterinary Clinics
5) Animal Farms
6) Animal Markets
7) Food Manufacturers
8) Travel (Airlines, Cruise operators)
Abstract
A survey conducted by the British Medical Association found that half of doctors working in high risk environments do not have access to appropriate face masks. Also, the British Dental Association has lamented the typical UK dentist who can go through 250 face masks per week is now restricted to 100 no matter the practice size. A study by HSE and PHE on the use of PPE in health care settings published on the 27th of March recommended the use of FFP3 but if not available FFP2 and N95 masks can be used. However, there is no certified manufacturing of face masks in the UK and there is only one manufacturer of spunbond and meltblown nonwoven medical fabrics, a material used for FFP2/N95 disposable respirators.
Pharm2Farm (Lead) and Flexotronix (subcontractor) aim to combine their leading nanotechnology capabilities to produce a highly enhanced anti-viral face mask to meet N95/FFP2 and FFP3 specifications.
Ref: https://gtr.ukri.org/projects?ref=63429
Avacta (AVCT): Corp
Avacta remains on track to meet its key Q4 2020 milestones, namely (i) complete first pilot batch and carry out a clinical
evaluation of the professional use of SARS-CoV-2 rapid antigen test, (ii) clinical evaluation and partnership for the
BAMS™ SARS-CoV-2 test and (iii) UK regulatory filing for AVA6000 (pre|CISION™ chemotherapy). Confirmation that BBI
Solutions has developed a scalable manufacturing process for the SARS-CoV-2 antigen test with very good analytical
sensitivity, using laboratory samples of COVID-19, is a key milestone that de-risks this programme further. Near-term, we
expect data from clinical evaluations highlighting the sensitivity and specificity of the antigen test to be released, before
the final clinical validation, using final production batch tests, is undertaken. We maintain our target price of 310p (with a
range of 211-796p).
COVID-19 freedom pass gives investors more reasons to be cheerful:
Investors in some of the more popular COVID-19 testing stocks such as Novacyt, Avacta and Omega Diagnostics will be particularly interested in this development.
https://www.sharebuyers.co.uk/shares/covid-19-freedom-pass-gives-investors-reasons-to-be-cheerful/
Everyone should be tested for coronavirus every month to give people “freedom passes” to resume everyday activities, Jeremy Hunt says.
The former health secretary today urges Boris Johnson to set an Easter deadline to return to more normal life through mass testing with rapid home testing kits, even if vaccines have not come through by then.
https://www.thetimes.co.uk/article/jeremy-hunt-take-test-to-earn-freedom-pass-g3q8bs35l
Incompetence and Errors in Reasoning Around Face Covering
https://medium.com/incerto/the-masks-masquerade-7de897b517b7
"A vaccine will complement the other tools we have, not replace them," director-general Tedros Adhanom Ghebreyesus said. "A vaccine on its own will not end the pandemic."
https://medicalxpress.com/news/2020-11-vaccine-pandemic-chief.html
https://twitter.com/LilianGreenwood/status/1326503366889967617
Great to see Nottingham research & development leading the way once again. Congratulations
@Pharm2Farm_org
@BioCity
@TrentUni
Moderna's CEO says vaccines aren't a 'silver bullet' — masks and social distancing are still the best defenses against the virus right now.
https://www.businessinsider.com/moderna-ceo-vaccines-are-not-silver-bullet-must-wear-masks-2020-11?r=US&IR=T
To substantiate,
CONDOR + AVACTA
https://avacta.com/update-on-clinical-validation-of-adeptrix-covid-19-diagnostic-test/
Dr. Mark Kortepeter, a physician and biodefense expert who has been involved in combating multiple epidemics, discusses five reasons why wearing masks will continue to be an important infection prevention tool long after the first Covid-19 vaccine.
Reference:
https://www.forbes.com/sites/coronavirusfrontlines/2020/10/20/why-youll-still-need-to-wear-a-mask-even-after-covid-19-vaccines-arrive/
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-test-detects-neutralizing-antibodies-recent-or
“The ability to detect neutralizing antibodies can help us gain additional insight into what the existence of antibodies may mean for patients as we continue the fight against COVID-19,” said Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health. “There are still many unknowns about what the presence of SARS-CoV-2 antibodies may tell us about potential immunity, but today’s authorization gives us another tool to evaluate those antibodies as we continue to research and study this virus.
If you are sceptical of usage of masks by general public post vaccination, here is a list where it will be needed forever.
1) World Health Organization ("To meet rising global demand, WHO estimates that industry must increase manufacturing of PPE by 40 per cent.") - Purchase & Distribute to at-risk countries
2) Hospitals throughout the globe
3) Veterinary Clinics
4) Animal Farms
5) Animal Markets
6) Travel (Airlines, Cruise)
Please feel free to add more..
https://twitter.com/cigahealthcare/status/1327236601932632068
Notlucky,
Production will be in Nottingham..
"Pharm 2 Farm is focusing on bringing its mask to market as soon as possible. The Directors' expectation is that the mask production line will be delivered and installed in its clean room facility at BioCity Nottingham at the end of this month and that production can begin shortly thereafter."